Global Topical Drugs Market 2022-2026 – Technological Advances in Drug Delivery Systems and a Strong Pipeline will Lead to Sizable Demand – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Topical Drugs Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering.

The market is poised to grow by $70.95 bn during 2022-2026, accelerating at a CAGR of 7.73%.

The market is driven by an increase in the prevalence of skin diseases, the growth of the geriatric population, and product launches.

This study identifies the use of 3D printing technology as one of the prime reasons driving the topical drugs market growth during the next few years. Also, technological advances in the topical drug delivery system and a strong pipeline will lead to sizable demand in the market.

The report on the topical drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The topical drugs market analysis includes product segment and geographic landscape.

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading topical drugs market vendors. Also, the topical drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

Key Topics Covered:

1 Executive Summary

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition

3.2 Market segment analysis

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026

4 Five Forces Analysis

4.1 Five forces summary

4.2 Bargaining power of buyers

4.3 Bargaining power of suppliers

4.4 Threat of new entrants

4.5 Threat of substitutes

4.6 Threat of rivalry

4.7 Market condition

5 Market Segmentation by Product

5.1 Market segments

5.2 Comparison by Product

5.3 Semi solid – Market size and forecast 2021-2026

5.4 Liquid – Market size and forecast 2021-2026

5.5 Solid – Market size and forecast 2021-2026

5.6 Market opportunity by Product

6 Customer Landscape

6.1 Customer landscape overview

7 Geographic Landscape

7.1 Geographic segmentation

7.2 Geographic comparison

7.3 North America – Market size and forecast 2021-2026

7.4 Europe – Market size and forecast 2021-2026

7.5 Asia – Market size and forecast 2021-2026

7.6 Rest of World (ROW) – Market size and forecast 2021-2026

7.7 US – Market size and forecast 2021-2026

7.8 Germany – Market size and forecast 2021-2026

7.9 China – Market size and forecast 2021-2026

7.10 UK – Market size and forecast 2021-2026

7.11 Canada – Market size and forecast 2021-2026

7.12 Market opportunity By Geographical Landscape

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape

9.3 Landscape disruption

9.4 Industry risks

10 Vendor Analysis

10.1 Vendors covered

10.2 Market positioning of vendors

• 3M Corp.
• AbbVie Inc.
• Bausch Health Companies Inc.
• Bayer AG
• Cipla Ltd.
• CMP Pharma Inc.
• Crescita Therapeutics Inc.
• GlaxoSmithKline Plc
• Hisamitsu Pharmaceutical Co. Inc.
• Johnson and Johnson
• MedPharm Ltd.
• Nestle SA
• Pfizer Inc.
• Sheffield Pharmaceuticals LLC
• Sol-Gel Technologies Ltd.
• Sun Pharmaceutical Industries Ltd.
• Teligent Inc.
• Viatris Inc.

For more information about this report visit https://www.researchandmarkets.com/r/dlckgo

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900